BRIDGER MANAGEMENT, LLC filings

This page lists the SEC filings reported by BRIDGER MANAGEMENT, LLC.

SEC filings by BRIDGER MANAGEMENT, LLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2022-02-14BRIDGER MANAGEMENT, LLCSurrozen, Inc./DE00.0%EDGAR
SC 13G/A2021-02-16BRIDGER MANAGEMENT, LLCAtara Biotherapeutics, Inc.1,524,7601.8%EDGAR
SC 13G2020-11-30BRIDGER MANAGEMENT, LLCConsonance-HFW Acquisition Corp.700,0008.8%EDGAR
SC 13G/A2020-02-14BRIDGER MANAGEMENT, LLCAtara Biotherapeutics, Inc.2,932,8655.4%EDGAR
SC 13G/A2020-02-14BRIDGER MANAGEMENT, LLCDicerna Pharmaceuticals Inc1,981,6332.9%EDGAR
SC 13G/A2020-02-14BRIDGER MANAGEMENT, LLCTG THERAPEUTICS, INC.1,907,4921.9%EDGAR
SC 13G/A2020-02-14BRIDGER MANAGEMENT, LLCDicerna Pharmaceuticals Inc1,981,6332.9%EDGAR
SC 13G2019-11-01BRIDGER MANAGEMENT, LLCAtara Biotherapeutics, Inc.2,932,8655.5%EDGAR
SC 13G2019-03-11BRIDGER MANAGEMENT, LLCTG THERAPEUTICS, INC.4,991,5315.7%EDGAR
SC 13G/A2019-02-14BRIDGER MANAGEMENT, LLCAtara Biotherapeutics, Inc.2,206,9174.8%EDGAR
SC 13G/A2019-02-14BRIDGER MANAGEMENT, LLCDicerna Pharmaceuticals Inc4,773,7187.6%EDGAR
SC 13G/A2019-02-14BRIDGER MANAGEMENT, LLCTG THERAPEUTICS, INC.3,791,5314.6%EDGAR
SC 13G2018-06-21BRIDGER MANAGEMENT, LLCDicerna Pharmaceuticals Inc3,056,7795.8%EDGAR
SC 13G/A2018-02-14BRIDGER MANAGEMENT, LLCAtara Biotherapeutics, Inc.2,598,5998.5%EDGAR
SC 13G/A2018-02-14BRIDGER MANAGEMENT, LLCTG THERAPEUTICS, INC.4,391,6346.2%EDGAR
SC 13G2017-04-21BRIDGER MANAGEMENT, LLCAtara Biotherapeutics, Inc.1,524,1915.2%EDGAR
SC 13G/A2017-02-14BRIDGER MANAGEMENT, LLCTrovagene, Inc.00.0%EDGAR
SC 13G/A2017-02-14BRIDGER MANAGEMENT, LLCTG THERAPEUTICS, INC.4,921,0599.0%EDGAR
SC 13G/A2017-02-14BRIDGER MANAGEMENT, LLCSeaSpine Holdings Corp00.0%EDGAR
SC 13G/A2017-02-14BRIDGER MANAGEMENT, LLCPACIFIC BIOSCIENCES OF CALIFORNIA, INC.00.0%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.